Necrotizing fasciitis: treatment concepts and clinical results

Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014;51(8):344–62.

Pfanner W. Zur Kenntnis und Behandlung des nekrotisierenden Erysipels. Deutsche Zeitschrift für Chirurgie. 1918;144(1–2):108.

Wilson B. Necrotizing fasciitis. Am Surg. 1952;18(4):416–31.

Frank J, Barker JH, Marzi I. Necrotizing fasciitis of the extremities. Eur J Trauma Emerg Surg. 2008;34(3):229.

Herr M, Grabein B, Palm HG. Nekrotisierende Fasziitis. Der Unfallchirurg. 2011;114(3):197–216.

Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014;1:36.

Lamagni TL, Darenberg J, Luca-Harari B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2008;46(7):2359–67.

Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996;335(8):547–54.

Ryssel H, Germann G, Kloeters O, et al. Necrotizing fasciitis of the extremities: 34 cases at a single centre over the past 5 years. Arch Orthop Trauma Surg. 2010;130(12):1515–22.

Lacy MD, Horn K. Nosocomial transmission of invasive group a streptococcus from patient to health care worker. Clin Infect Dis. 2009;49:354–7.

Johansson L, Thulin P, Low DE, et al. Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin Infect Dis. 2010;51(1):58–65.

Zhu L, Olsen RJ, Nasser W, et al. A molecular trigger for intercontinental epidemics of group A Streptococcus. J Clin Investig. 2015;125(9):3545–59.

O’Seaghdha M, Wessels MR. Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from xenophagic killing. PLoS Pathog. 2013;9(6):e1003394.

Sarani B, Strong M, Pascual J, et al. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208(2):279–88.

Machado N. Necrotizing fasciitis: the importance of early diagnosis, prompt surgical debridement and adjuvant therapy. North Am J Med Sci. 2011;3(3):107.

Chen JL, Fullerton KE, Flynn NM. Necrotizing fasciitis associated with injection drug use. Clin Infect Dis. 2001;33(1):6–15.

Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445–53.

Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–41.

Goh T, Goh LG, Ang CH, et al. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101(1):e119–25.

Wang YS, Wong CH, Tay YK. Staging of necrotizing fasciitis based on the evolving cutaneous features. Int J Dermatol. 2007;46(10):1036–41.

Wall DB, Virgilio C, Black S, et al. Objective criteria may assist in distinguishing necrotizing fasciitis from nonnecrotizing soft tissue infection. Am J Surg. 2000;179:17–21.

Narashiman V, Ooi G, Weidlich S, et al. Laboratory risk indicator for necrotizing fasciitis score for early diagnosis of necrotizing fasciitis in Darwin. ANZ J Surg. 2017. (Epub ahead of print).

El-Menyar A, Asim M, Mudali IN, et al. The laboratory risk indicator for necrotizing fasciitis (LRINEC) scoring: the diagnostic and potential prognostic value. Scand J Trauma Resusc Emerg Med. 2017;25(1):28.

Burner E, Henderson SO, Burke G, et al. Inadequate sensitivity of laboratory risk indicator to rule out necrotizing fasciitis in the emergency department. West J Emerg Med. 2016;17(3):333–6.

Tan JH, Koh BT, Hong CC, et al. A comparison of necrotising fasciitis in diabetics and non- diabetics: a review of 127 patients. Bone Joint J. 2016;98-B(11):1563–1568.

Carbonetti F, Cremona A, Carusi V, et al. The role of contrast enhanced computed tomography in the diagnosis of necrotizing fasciitis and comparison with the laboratory risk indicator for necrotizing fasciitis (LRINEC). Radiol Med. 2015; [Epub ahead of print].

Sun X, Xie T. Management of necrotizing fasciitis and its surgical aspects. Int J Low Extrem Wounds. 2015;14(4):328–34.

Bilton BD, Zibari GB, McMillan RW, et al. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg. 1998;64(5):397–400.

Wong CH, Yam AK, Tan AB, et al. Approach to debridement in necrotizing fasciitis. Am J Surg. 2008;196(3):e19–24.

Hietbrink F, Bode LG, Riddez L, et al. Triple diagnosis for early detection of ambivalent necrotizing fasciitis. World J Emerg Surg. 2016;11:51.

Misiakos EP, Bagias G, Papadopoulos I, et al. Early diagnosis and surgical treatment for necrotizing fasciitis: a multicenter study. Front Surg. 2017;4:5.

Wall DB, Klein SR, Black S, et al. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Sure. 2000;191(3):227–31.

Burnham JP, Kirby JP, Kolleg MH. Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review. Intensive Care Med. 2016;42:1899–911.

Chester DL, Waters R. Adverse alteration of wound flora with topical negative-pressure therapy: a case report. Br J Plast Surg. 2002;55:510–1.

Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. S2-Leitlinie HNO: Antibiotikatherapie der Infektionen an Kopf und Hals, 2008.

Khamnuan P, Chongruksut W, Jearwarttanakanok K, et al. Necrotizing fasciitis: epidemiology and clinical predictors for amputation. Int J Gen Med. 2015;8:195–202.

Cheng NC, Tai HC, Chang SC, et al. Necrotizing fasciitis in patients with diabetes mellitus: clinical characteristics and risk factors for mortality. BMC Infect Dis. 2015;15:417.

Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg. 1996;224(5):672–83.

Frazee BW, Fee C, Lynn J, et al. Community-acquired necrotizing soft tissue infections: a review of 122 cases presenting to a single emergency department over 12 years. J Emer Med. 2008;34(2):139–46.

Dworkin M, Westercamp M, Park L, et al. The epidemiology of necrotising fasciitis including factors associated with death and amputation. Epidemiol Infect. 2009;137:1609–14.

Nisbet M, Ansell G, Lang S, Dzendrowskyj P, Holland D, et al. Necrotising fasciitis: review of 82 cases in South Auckland. Intern Med J. 2011;47:543–8.

Wong CH, Chang HC, Pasupathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85(8):1454–60.

Singh G, Sinha S, Adhikary S, et al. Necrotising infections of soft tissues—a clinical profile. Eur J Surg. 2002;168:366–71.

Hsiao CT, Weng HH, Yuan YD, et al. Predictors of mortality in patients with necrotizing fasciitis. Am J Emerg Med. 2008;26(2):170–5.

Huang KF, Hung MH, Lin YS, et al. Independent predictors of mortality for necrotising fasciitis: a retrospective analysis in a single institution. J Trauma. 2011;71:467–73.

Park KH, Jung SI, Jung YS, et al. Marine bacteria as a leading cause of necrotizing fasciitis in coastal areas of South Korea. Am J Trop Med Hyg. 2009;80(4):646–50.